PR Newswire Clinical TrialsOriginal article
Mirxes觅瑞精准诊疗管线商业化提速，原发灶不明癌检测DisCUOver在新加坡上线
DisCUOverPositive
AI Analysis
Summary
Mirxes announced the launch of its DisCUOver diagnostic product for Cancer of Unknown Origin at its Singapore clinical laboratory M Diagnostics. The launch represents the company's continued commercialization efforts in its precision diagnostics platform.
Outcome Details
Product launch in Singapore clinical laboratory
Importance:5/10
Sentiment:
0.60
commercializationproduct launchdiagnosticSingaporeprecision medicine
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 28, 2026 6:36 AM